XML 13 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Aug. 31, 2025
Aug. 31, 2024
Operating activities:    
Net earnings $ 34,821 $ 24,008
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 13,086 11,830
Provision for (benefit from) deferred income taxes 2,957 (5,537)
Bad debt income (21) (8)
Equity in net income of unconsolidated affiliates, net of distributions (181) 3,453
Net gain on sale of assets   (18)
Stock-based compensation 3,427 3,925
Changes in assets and liabilities, net of impact of acquisitions:    
Receivables 14,107 28,166
Inventories (15,816) (6,406)
Accounts payable (11,946) (13,093)
Accrued compensation and employee benefits (10,399) (11,445)
Other operating items, net 11,026 6,271
Net cash provided by operating activities 41,061 41,146
Investing activities:    
Investment in property, plant and equipment (13,195) (9,629)
Acquisitions, net of cash acquired (92,235) (88,887)
Proceeds from sale of assets, net of selling costs   11,769
Investment in non-marketable equity securities   (2,000)
Net cash used by investing activities (105,430) (88,747)
Financing activities:    
Dividends paid (8,576) (8,116)
Repurchase of common shares (6,259) (6,803)
Proceeds from issuance of common shares, net of tax withholdings (3,552) (3,158)
Principal payments on long-term obligations (197)  
Net cash used by financing activities (18,584) (18,077)
Decrease in cash and cash equivalents (82,953) (65,678)
Cash and cash equivalents at beginning of period 250,075 244,225
Cash and cash equivalents at end of period $ 167,122 $ 178,547